Hong Zhang

Hong Zhang, M.D., Ph.D., is a Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. She specializes in advanced radiation therapy techniques for prostate, breast, and head/neck cancers, with a focus on personalized treatment and compassionate patient care. Her work bridges clinical practice and translational research.

• Education: M.D. and Ph.D. from Yale University School of Medicine and Case Western Reserve University School of Medicine
• Residency: Radiation Oncology at University of Rochester Medical Center
• Certifications: American Board of Radiology

Her research explores radiation-induced toxicity reduction, biomarker analysis, and oligometastatic disease management. She leads clinical trials integrating advanced imaging and pharmacological agents like lisinopril into prostate cancer radiotherapy, while investigating long-term outcomes for cancers treated with stereotactic techniques.

Hong Zhang's publications highlight innovations in radiation dose optimization, rectal spacers, and stereotactic radiotherapy for oligometastatic cancers. These works span prostate, breast, and lung metastasis research, with a recurring emphasis on patient-centered outcomes and technological advancements.

• Exceptional Women in Medicine (2024, 2023)
• Health Care Achievement Awards--Health Care Innovation (2017)
• Educator of the Year (2016, 2012)
• ASTRO Travel Grant (2005)
• Clyde Swift Award for Outstanding Medical Student (2000)

As lead researcher on multiple clinical trials, she investigates radiation dose optimization for prostate cancer and hormonal therapy integration for oligometastatic disease. Her 451 patient ratings (5/5 stars) underscore her commitment to thorough, patient-centered care and clear communication of complex treatment options.